Suchergebnisse - "Milla, Carlos"

PubPharm (12)

1

Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis : A Clinical Trial

enthalten in: American journal of respiratory and critical care medicine | 2022

von Nichols, D. | Paynter, A. | Heltshe, S. | +121

CommentIn: Am J Respir Crit Care Med. 2022 Mar 1;205(5):487-489. - PMID 35073504

2

Sweat rate analysis of ivacaftor potentiation of CFTR in non-CF adults

enthalten in: Scientific reports | 2018

von Kim, J. | Farahmand, M. | Dunn, C. | +5

3

Ivacaftor treatment of cystic fibrosis in children aged 12 to <24 months and with a CFTR gating mutation (ARRIVAL) : a phase 3 single-arm study

enthalten in: The Lancet. Respiratory medicine | 2018

von Rosenfeld, M. | Wainwright, C. | Higgins, M. | +38

CommentIn: Lancet Respir Med. 2018 Jul;6(7):483-484. - PMID 29886025

4

Ivacaftor restores CFTR-dependent sweat gland fluid secretion in cystic fibrosis subjects with S945L alleles

enthalten in: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society | 2018

von Kim, J. | Davies, Z. | Dunn, C. | +2

5

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6-11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2017

von Ratjen, F. | Hug, C. | Marigowda, G. | +62

CommentIn: Lancet Respir Med. 2017 Jul;5(7):536-537. - PMID 28606619

6

Lumacaftor/Ivacaftor in Patients Aged 6-11 Years with Cystic Fibrosis and Homozygous for F508del-CFTR

enthalten in: American journal of respiratory and critical care medicine | 2017

von Milla, C. | Ratjen, F. | Marigowda, G. | +4

CommentIn: Am J Respir Crit Care Med. 2017 Apr 1;195(7):849-850. - PMID 28362199

7

The magnitude of ivacaftor effects on fluid secretion via R117H-CFTR channels : Human in vivo measurements

enthalten in: PloS one | 2017

von Char, J. | Dunn, C. | Davies, Z. | +3

8

Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis

enthalten in: American journal of respiratory and critical care medicine | 2014

von Rowe, S. | Heltshe, S. | Gonska, T. | +52

CommentIn: Am J Respir Crit Care Med. 2014 Jul 15;190(2):128-9. - PMID 25025350

9

A little CFTR goes a long way : CFTR-dependent sweat secretion from G551D and R117H-5T cystic fibrosis subjects taking ivacaftor

enthalten in: PloS one | 2014

von Char, J. | Wolfe, M. | Cho, H. | +9

10

Assessment of clinical response to ivacaftor with lung clearance index in cystic fibrosis patients with a G551D-CFTR mutation and preserved spirometry : a randomised controlled trial

enthalten in: The Lancet. Respiratory medicine | 2013

von Davies, J. | Sheridan, H. | Bell, N. | +8

CommentIn: Lancet Respir Med. 2013 Oct;1(8):591-2. - PMID 24461654